Eukarÿs SAS

Eukarÿs is a biotechnology company which develops high performance high yield In Vitro Transcription(IVT) systems for cell-free mRNA production, based on its novel C3P3® technology, a non-viral expression technology.
C3P3® Technology.
The patent granted C3P3® technology enables to develop highly processive transcription systems thanks to the combined use of a new kind of single-unit RNA polymerase and specific DNA templates to produce high yields of fully mature eukaryotic-like mRNA molecules (native 5’-cap and 3’-polyadenylation with non-phosphorylated capped 5’-ends).